New combo pill for high blood pressure under Real-World watch

NCT ID NCT05413057

Recruiting now Disease control Sponsor: Boryung Pharmaceutical Co., Ltd Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 29 times

Summary

This study is for adults with high blood pressure who are taking a single pill that combines two or three medicines (fimasartan/amlodipine with or without hydrochlorothiazide). The main goal is to see how well the pill controls blood pressure and what side effects occur over 12 weeks. A smaller group will be followed for about 2 years to check long-term blood pressure control and major heart events. The study is observational, meaning researchers just watch and collect data without giving any extra treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION,ESSENTIAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Seoul National University Bundang Hospital
RECRUITING

Seoul, South Korea

Contact

Contact

Conditions

Explore the condition pages connected to this study.

HYPERTENSION,ESSENTIAL